IVIG [invenous immune globulin] Treatment for Live-Donor Renal Transplant Patients With a Positive Crossmatch and in Patients With High PRA [panel reactive antibody].
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Immune globulin (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 09 Jan 2017 Biomarkers information updated
- 14 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 14 Oct 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.